CD47 and metastatic malignant neoplasm in the lymph nodes: Our results confirmed the observation of the most previously reported studies that high CD47 expression was associated to a poor prognosis, as well as the significant correlations with clinicopathological features, including advanced FIGO stage, lymph-node metastasis, chemotherapy resistance, and high serum CA125 value.